Furthermore, beyond the immediate trial, there is a broader potential for approval and product launches from Rocket’s lentiviral vector-based therapies, which adds to the investment case. The Phase 2 ...

Analyst Cory Jubinville, PhD of LifeSci Capital maintained a Buy rating on Rocket Pharmaceuticals (RCKT – Research Report), retaining the ...

Given the prevalence of Danon disease across regions, the Company plans to pursue regulatory filings concomitantly in the U.S. and ex-U.S. “From a clinical perspective, the important thing is that we ...

Happy butterscotch pudding day from the wBW team! We’ve put together the freshest news from our good industry.

Of course, then all of them — Yeltsin, Shushkevich, Kravchuk — said at every corner that they had decided to renew the USSR ...

A safe environment of protected rights and freedoms. Responsible citizens — responsible for their own development, well-being ...

Australia and India are expanding their space collaboration, focusing on supporting India's Gaganyaan mission and launching ...

The company said the single-arm multicenter Phase II trial may support accelerated approval for the RP-A501 gene therapy in the US.

The darkest-darkest timeline is the one where the world’s richest man runs a communications platform in a truly vengeful, ...

Ukraine will likely receive a number of AGM-154 Joint Standoff Weapon (JSOW) glide munitions in a new $375 million U.S. aid ...

The space company is targeting Tuesday, Sept. 17, to launch a Falcon 9 rocket from Launch Complex 40 at Cape Canaveral Space Force Station, a Federal Aviation Administration operations plan ...

See how we rate mortgages to write unbiased product reviews. Business Insider's personal finance team reviewed Rocket Mortgage and found it to be one of the best mortgage lenders and an industry ...